Upgrade to SI Premium - Free Trial

Abbott Labs (ABT) PT Raised to $117 at Bernstein SocGen Group

July 17, 2026 8:48 AM
Bernstein SocGen Group analyst Lee Hambright raised the price target on Abbott Labs (NYSE: ABT) to $117.00 (from $110.00) while maintaining a Outperform rating.

Categories

Analyst PT Change